Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: Background, aims and design of the ELANDD study

Clinical Research in Cardiology

Volumn 99, Issue 2, 2010, Pages 75-82

  Kamp, Otto ^a   Metra, Marco ^b   De Keulenaer, Gilles W ^c,d   Pieske, Burkert ^e   Conraads, Viviane ^f   Zamorano, José ^g   Huysse, Lieven ^h   Vardas, Panos E ⁱ   Böhm, Michael ^j   Cas, Livio Dei ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d MIDDELHEIM HOSPITAL   (Belgium)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h Menarini Benelux NV/SA   (Belgium)

ⁱ UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^j SAARLAND UNIVERSITY   (Germany)

more..

Author keywords

6 MWT; ELANDD; HFPEF (heart failure preserved ejection fraction); Nebivolol; Quality of life

Indexed keywords

NEBIVOLOL; PLACEBO;

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOPULMONARY EXERCISE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG SCREENING; EXERCISE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYMPTOM;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BENZOPYRANS; COMORBIDITY; DRUG TOXICITY; ETHANOLAMINES; EUROPE; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77949889127     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-009-0098-x     Document Type: Article

References (34)

1. F Bursi SA Weston MM Redfield SJ Jacobsen S Pakhomov VT Nkomo RA Meverden VL Roger 2006 Systolic and diastolic heart failure in the community JAMA 296 18 2209 2216 10.1001/jama.296.18.2209 1:CAS:528:DC%2BD28XhtFKrtb%2FI 17090767 (Pubitemid 44708051)
2. RS Vasan EJ Benjamin D Levy 1995 Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective J Am Coll Cardiol 26 1565 1574 10.1016/0735-1097(95)00381-9 1:STN:280: DyaK28%2FotlGhtA%3D%3D 7594087
3. European Society of Cardiology, Heart Failure Association of the ESC (HFA), European Society of Intensive Care Medicine (ESICM), Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Tendera M, Auricchio A, Bax J, Böhm M, Corrà U, della Bella P, Elliott PM, Follath F, Gheorghiade M, Hasin Y, Hernborg A, Jaarsma T, Komajda M, Kornowski R, Piepoli M, Prendergast B, Tavazzi L, Vachiery JL, Verheugt FW, Zamorano JL, Zannad F (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10:933-989
4. WJ Paulus C Tschöpe JE Sanderson C Rusconi FA Flachskampf FE Rademakers P Marino OA Smiseth G De Keulenaer AF Leite-Moreira A Borbély I Edes ML Handoko S Heymans N Pezzali B Pieske K Dickstein AG Fraser DL Brutsaert 2007 How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 20 2539 2550 10.1093/eurheartj/ehm037 17428822 (Pubitemid 47614269)
5. MJ Lenzen WJ Scholte op Reimer E Boersma PJ Vantrimpont F Follath K Swedberg J Cleland M Komajda 2004 Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey Eur Heart J 25 1214 1220 10.1016/j.ehj.2004.06.006 1:STN:280: DC%2BD2czktlSnsw%3D%3D 15246639 (Pubitemid 38891571)
6. JS Gottdiener RL McClelland R Marshall L Shemanski CD Furberg DW Kitzman M Cushman J Polak JM Gardin BJ Gersh GP Aurigemma TA Manolio 2002 Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study Ann Intern Med 137 631 639 12379062 (Pubitemid 35176095)
7. C Tribouilloy D Rusinaru H Mahjoub V Soulière F Lévy M Peltier M Slama Z Massy 2008 Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study Eur Heart J 29 339 347 10.1093/eurheartj/ehm554 18156618 (Pubitemid 351197754)
8. DJ van Veldhuisen A Cohen-Solal M Böhm SD Anker D Babalis M Roughton AJ Coats PA Poole-Wilson MD Flather SENIORS Investigators 2009 Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (study of effects of nebivolol intervention on outcomes and rehospitalization in seniors with heart failure) J Am Coll Cardiol 53 2150 2158 10.1016/j.jacc.2009.02.046 19497441
9. S Yusuf MA Pfeffer K Swedberg CB Granger P Held JJ McMurray EL Michelson B Olofsson J Ostergren CHARM Investigators Committees 2003 Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial Lancet 362 777 781 10.1016/S0140-6736(03)14285-7 1:CAS:528:DC%2BD3sXntVGktLg%3D 13678871 (Pubitemid 37093918)
10. Metra M, Brutsaert D, Dickstein K, Fraser AG, Bergh CH, Böhm M, Gavazzi A, Jaarsma T, Ponikowski P, Komajda M, On Behalf of The Study Group on Advanced Heart Failure of The Heart Failure Association of The European Society of Cardiology (2007) Treatment of advanced chronic heart failure with normal left ventricular ejection fraction. Response to the letter by Dr. Martinez-Selles. Eur J Heart Fail 9:1224-1225 (Pubitemid 350153638)
11. L Rony A Shammas U Nazim K Azam R Nekkantia A Movahed 2007 Diastolic heart failure and left ventricular diastolic dysfunction: what we know, and what we don't know! Int J Cardiol 115 284 292 10.1016/j.ijcard.2006.03.027 (Pubitemid 46201713)
12. DIG Investigators 1997 The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group N Engl J Med 336 525 533 10.1056/NEJM199702203360801 (Pubitemid 27085732)
13. MD Flather MC Shibata AJ Coats DJ Van Veldhuisen A Parkhomenko J Borbola A Cohen-Solal D Dumitrascu R Ferrari P Lechat J Soler-Soler L Tavazzi L Spinarova J Toman M Böhm SD Anker SG Thompson PA Poole-Wilson SENIORS Investigators 2005 Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 215 225 10.1093/eurheartj/ehi115 1:CAS:528:DC%2BD2MXksFCgtbc%3D 15642700 (Pubitemid 40222359)
14. JG Cleland M Tendera J Adamus N Freemantle L Polonski J Taylor PEP-CHF Investigators 2006 The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2338 2345 10.1093/eurheartj/ehl250 1:CAS:528:DC%2BD28Xht1Sgu7zN 16963472 (Pubitemid 44453578)
15. BM Massie PE Carson JJ McMurray M Komajda R McKelvie MR Zile S Anderson M Donovan E Iverson C Staiger A Ptaszynska I-PRESERVE Investigators 2008 Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2456 2467 10.1056/NEJMoa0805450 1:CAS:528:DC%2BD1cXhsVCrurjE 19001508
16. European Study Group on Diastolic Heart Failure 1998 How to diagnose diastolic heart failure Eur Heart J 19 990 1003 10.1053/euhj.1998.1057 (Pubitemid 28321378)
17. LJ Ignarro RE Byrns K Trinh M Sisodia GM Buga 2002 Nebivolol: a selective beta(1)-adrenergic receptor antagonist that relaxes vascular smooth muscle by nitric oxide- and cyclic GMP-dependent mechanisms Nitric Oxide 7 75 82 10.1016/S1089-8603(02)00112-X 1:CAS:528:DC%2BD38Xms1yrs7c%3D 12223176 (Pubitemid 35176998)
18. C Dessy J Saliez P Ghisdal G Daneau II Lobysheva F Frérart C Belge K Jnaoui P Noirhomme O Feron JL Balligand 2005 Endothelial beta3- adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol Circulation 112 1198 1205 10.1161/CIRCULATIONAHA.104.532960 1:CAS:528: DC%2BD2MXnvFyltLY%3D 16116070 (Pubitemid 41216127)
19. WJ Paulus PJ Vantrimpont AM Shah 1994 Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion Circulation 89 2070 2078 1:STN:280:DyaK2c3js1OltQ%3D%3D 7910117
20. S Nodari M Metra L Dei Cas 2003 Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol Eur J Heart Fail 5 621 627 10.1016/S1388-9842(03)00054-0 1:CAS:528:DC%2BD3sXos1Olu7g%3D 14607201 (Pubitemid 38043967)
21. TS Rector JN Cohn 1992 Assessment of patient outcome with the Minnesota living with heart failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of Pimobendan. Pimobendan Multicenter Research Group Am Heart J 124 1017 1025 10.1016/0002-8703(92)90986-6 1:STN:280:DyaK38vhtFWisw%3D%3D 1529875
22. DJ Sahn A DeMaria J Kisslo A Weyman 1978 The Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 8 1072 1083
23. RB Devereux DR Alonso EM Lutas GJ Gottlieb E Campo I Sachs N Reichek 1986 Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 450 458 10.1016/0002-9149(86)90771-X 1:STN:280:DyaL287islSkug%3D%3D 2936235 (Pubitemid 16119719)
24. O Kamp GT Sieswerda CA Visser 2003 Comparison of effect on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension Am J Cardiol 92 344 348 10.1016/S0002-9149(03)00645-3 1:CAS:528:DC%2BD3sXlvVWit7s%3D 12888152 (Pubitemid 36897730)
25. SR Ommen RA Nishimura CP Appleton FA Miller JK Oh MM Redfield AJ Tajik 2000 Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study Circulation 102 1788 1794 1:STN:280: DC%2BD3cvnvVagsA%3D%3D 11023933
26. DJ Guyatt MJ Sullivan PJ Thompson EL Fallen SO Pugsley DW Taylor LB Berman 1985 The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure Can Med Assoc J 132 919 923 1:STN:280: DyaL2M7ltFCksw%3D%3D 3978515
27. M Metra L Dei Cas G Panina O Visioli 1992 Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics Am J Cardiol 70 622 628 10.1016/0002-9149(92)90202-A 1:STN:280:DyaK38znslOjtw%3D%3D 1510011
28. M Metra R Giubbini S Nodari E Boldi MG Modena L Dei Cas 2000 Differential effects of beta-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol Circulation 102 546 551 1:CAS:528:DC%2BD3cXlvFKhur0%3D 10920067 (Pubitemid 30642529)
29. JG Cleland J Taylor M Tendera 2007 Prognosis in heart failure with a normal ejection fraction N Engl J Med 357 829 830 10.1056/NEJMc076179 1:CAS:528:DC%2BD2sXps1Sltbs%3D 17715420 (Pubitemid 47295663)
30. H Persson E Lonn M Edner L Baruch CC Lang JJ Morton J Ostergren RS McKelvie Investigators of the CHARM Echocardiographic Substudy-CHARMES 2007 Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES J Am Coll Cardiol 49 687 694 10.1016/j.jacc.2006.08.062 17291934 (Pubitemid 46205045)
31. A Bergström B Andersson M Edner E Nylander H Persson U Dahlström 2004 Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC) Eur J Heart Fail 6 453 461 10.1016/j.ejheart.2004.02.003 15182771 (Pubitemid 38746589)
32. M Metra S Nodari D Raccagni M Garbellini E Boldi L Bontempi M Gaiti L Dei Cas 1998 Maximal and submaximal exercise testing in heart failure J Cardiovasc Pharmacol 32 Suppl 1 S36 S45 1:CAS:528:DyaK1cXlslKis74%3D 9731694 (Pubitemid 28415090)
33. M Metra P Ponikowski K Dickstein JJ McMurray A Gavazzi CH Bergh AG Fraser T Jaarsma A Pitsis P Mohacsi M Böhm S Anker H Dargie D Brutsaert M Komajda Heart Failure Association of the European Society of Cardiology 2007 Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 9 684 694 10.1016/j.ejheart.2007.04.003 17481947 (Pubitemid 46705572)
34. BA Borlaug V Melenovsky SD Russell K Kessler K Pacak LC Becker DA Kass 2006 Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction Circulation 114 2138 2147 10.1161/CIRCULATIONAHA.106.632745 17088459 (Pubitemid 44747894)